| View |
DR-XY14715_PI_01.pdf
|
DR-XY14715
|
Fluorouracil
|
None
|
50 mg/mL (500mg/10mL)
|
Solution For Injection (I.V.)
|
Antineoplastic Agent
|
Hospira Australia Pty. Ltd.
|
Australia
|
Automatic Renewal
|
10 May 2023
|
31 July 2028
|
| View |
|
DR-XY14730
|
Mannitol
|
Unbranded
|
20%
|
Solution For Injection
|
Hyperosmotic Agent
|
Euro-med Laboratories Phil. Inc.
|
Philippines
|
Renewal
|
24 August 2023
|
27 January 2029
|
| View |
|
DR-XY14753
|
Cefazolin Sodium
|
Lupex
|
1g
|
Powder For Injection (Im/Iv)
|
-
|
yung shin pharmaceutial ind. Co., ltd.
|
Taiwan
|
-
|
26 December 2019
|
31 January 2025
|
| View |
|
DR-XY14798
|
Ketorolac Trometamol
|
Toradol
|
30 mg/mL
|
Solution For Injection (Im/Iv)
|
Non-Opioid Analgesic
|
Cenexi
|
France
|
Automatic Renewal
|
13 December 2022
|
23 May 2028
|
| View |
|
DR-XY14851
|
Lisinopril
|
Zestril®
|
5 mg
|
Tablet
|
Antihypertensive
|
AstraZeneca Pharmaceutical Co. Ltd.
|
China
|
Renewal
|
01 March 2024
|
24 June 2029
|
| View |
|
DR-XY14852
|
Lisinopril
|
Zestril®
|
20 mg
|
Tablet
|
Antihypertensive
|
AstraZeneca Pharmaceutical Co. Ltd.
|
China
|
Renewal
|
12 February 2024
|
25 June 2029
|
| View |
|
DR-XY14853
|
Lisinopril (as dihydrate)
|
Zestril
|
10 mg
|
Tablet
|
Antihypertensive
|
AstraZeneca Pharmaceutical Co. Ltd.
|
China
|
Renewal
|
20 February 2024
|
11 February 2029
|
| View |
|
DR-XY14863
|
Multivitamins + Iron + Calcium
|
Sangobion Forte
|
360mg/1.5mg/15mcg/200mg/400IU/75mg
|
Capsule
|
Vitamins + Hematinic + Mineral
|
PT. Merck, Tbk.
|
Indonesia
|
Renewal
|
18 February 2024
|
05 March 2029
|
| View |
|
DR-XY14880
|
Warfarin Sodium (As Clathrate)
|
Coumadin
|
1mg
|
Tablet
|
-
|
Taro Pharmaceutical Industries Ltd.
|
Israel
|
Automatic Renewal (Re-Issuance)
|
02 August 2022
|
23 August 2025
|
| View |
|
DR-XY14899
|
Aluminum Hychloride Hexahydrate
|
Driclor
|
185 mg/mL
|
Solution
|
-
|
Stiefel Laboratories (Ireland) Ltd.
|
Ireland
|
-
|
23 October 2020
|
03 October 2025
|
| View |
|
DR-XY14900
|
Potassium Chloride
|
None
|
14.90%
|
Solution For Iv Infusion
|
-
|
B. Braun Medical Industries Sdn. Bhd.
|
Malaysia
|
-
|
30 September 2019
|
09 February 2025
|
| View |
|
DR-XY14904
|
Balanced Multiple Maintenance Solution/5% Dextrose
|
Plasma-Lyte 56
|
Each 100mL contains: Dextrose Hydrous Potassium Acetate Magnesium Acetate Tetrahydrate Sodium Chloride
5 mg 128 mg
32 mg 234 mg
|
Solution for IV Infusion
|
-
|
Baxter Healthcare Philippines Inc.
|
Philippines
|
-
|
10 November 2021
|
20 July 2025
|
| View |
|
DR-XY14914
|
5% Dextrose with Electrolytes Maintenance
|
Unbranded
|
(See Reverse)
|
Solution For Intravenous Infusion
|
Parenteral
|
Amherst Parenterals, Inc.
|
Philippines
|
Renewal
|
09 May 2024
|
12 April 2029
|
| View |
|
DR-XY14916
|
Loperamide Hydrochloride
|
Imodium
|
2 mg
|
Capsule
|
Antimotility
|
Interphil Laboratories
|
Philippines
|
Automatic Renewal
|
05 January 2023
|
07 July 2028
|
| View |
|
DR-XY14979
|
Cefalexin (as monohydrate)
|
Zeporin
|
250mg/5mL
|
Powder For Suspension
|
-
|
Drugmakers Laboratories, Inc.
|
Philippines
|
-
|
10 September 2021
|
03 February 2025
|
| View |
|
DR-XY15023
|
Salbutamol (as sulfate)
|
None
|
2 mg/5 mL
|
Syrup
|
Bronchodilator
|
Marnets Pharma Corporation
|
Philippines
|
Automatic Renewal
|
14 January 2022
|
15 October 2026
|
| View |
|
DR-XY15163
|
Doxorubicin Hydrochloride
|
None
|
2 mg/mL
|
Solution for Injection (IV or Intravesical)
|
Antineoplastic
|
Zydus Hospira Oncology Private Ltd. (ZHOPL)
|
Taluka
|
Automatic Renewal
|
14 October 2021
|
04 October 2025
|
| View |
|
DR-XY15192
|
Amoxicillin (as trihydrate)
|
Rielmox
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
Lloyd Laboratories Inc.
|
Philippines
|
Renewal
|
12 August 2024
|
29 December 2029
|
| View |
DR-XY15245_PI_01.pdf
|
DR-XY15245
|
Zuclopenthixol acetate
|
Clopixol- Acuphase
|
50mg/Ml
|
Solution for Injection (IM)
|
Antipsychotic ( Neuroleptic)
|
H. Lundbeck A/S
|
Denmark
|
Renewal
|
17 January 2024
|
24 June 2029
|
| View |
|
DR-XY15290
|
Calcipotriol
|
Daivonex
|
50 mcg/g (0.005%)
|
Ointment
|
Antipsoriatics
|
Leo Laboratories Ltd.
|
Ireland
|
Automatic Renewal
|
19 September 2022
|
15 October 2027
|